120 related articles for article (PubMed ID: 1100508)
1. B-chain shortening of matrix-bound insulin with pepsin, II. Preparation and properties of camel des-pentapeptide (B26-30)- and des-PheB1-des-pentapeptide (B26-30)- insulin.
Danho WO; Gattner HG; Nissen D; Zahn H
Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1405-12. PubMed ID: 1100508
[TBL] [Abstract][Full Text] [Related]
2. [B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].
Gattner HG
Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1397-404. PubMed ID: 240771
[TBL] [Abstract][Full Text] [Related]
3. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
[TBL] [Abstract][Full Text] [Related]
4. Structural studies on des-pentapeptide (B26-30)-insulin. I. The preparation and properties of des-pentapeptide-insulin.
Sci Sin; 1976; 19(3):351-7. PubMed ID: 788152
[TBL] [Abstract][Full Text] [Related]
5. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
Cosmatos A; Ferderigos N; Katsoyannis PG
Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
[TBL] [Abstract][Full Text] [Related]
7. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
8. A shortened insulin with full in vitro potency.
Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
[TBL] [Abstract][Full Text] [Related]
9. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
Schwartz G; Katsoyannis PG
Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-assisted semisynthesis of shortened B26-modified insulins.
Sievert D; Gattner HG; Lenz V; Höcker H
Biomed Biochim Acta; 1991; 50(10-11):S197-200. PubMed ID: 1820045
[TBL] [Abstract][Full Text] [Related]
12. [Preparation and properties of des-(pentapeptide-B26-30)-insulin].
Shvachkin IuP; Shmeleva GA; Krivtsov VF; Fedotov VP; Ivanova AI
Biokhimiia; 1972; 37(5):966-73. PubMed ID: 4564538
[No Abstract] [Full Text] [Related]
13. Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.
Hartmann H; Oberhaus K; Spahr R; Brandenburg D; Creutzfeldt W; Probst I
Diabetologia; 1989 Jul; 32(7):416-20. PubMed ID: 2680697
[TBL] [Abstract][Full Text] [Related]
14. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
Cara JF; Nakagawa SH; Tager HS
Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
[TBL] [Abstract][Full Text] [Related]
16. Shortened insulin with enhanced in vitro potency.
Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
[TBL] [Abstract][Full Text] [Related]
18. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
Mirmira RG; Tager HS
Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
[TBL] [Abstract][Full Text] [Related]
19. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
20. [Partial synthesis and properties of des-A1-glycine-insulin (author's transl)].
Brandenburg D; Biela M; Herbertz L; Zahn H
Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):961-79. PubMed ID: 1237459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
